Novel strain of bacillus amyloliquefaciens and its use
OwnerFeng-Chia Hsiehinventor
Life of this patent
Estimating the term…
Abstract
An isolated Bacillus amyloliquefaciens Ba-BPD1 having an Accession No. of DSM 21836 is provided. This novel strain has unique 16S ribosomal RNA sequenced as SEQ ID NO:1 and produces amylase, protease, cellulase and lipase, fibrinolytic enzyme to show their biodegradation capacities. Further, B. amyloliquefaciens Ba-BPD1 produces the antibiotic substances, such as iturin, fengycin and surfactin, and has antimicrobial capacity for inhibiting the fungal or bacterial growth. In conclusion, the novel strain of Bacillus amyloliquefaciens Ba-BPD1 and its products can be applied in agriculture, wastewater treatment, food industry and chemical industry.
Claims13
A use of an isolated microorganism of Bacillus amyloliquefaciens Ba-BPD1 with Accession No.:
- DSM 21836 and comprising 16S ribosomal RNA comprising a nucleotide sequence of SEQ ID NO:1, for protecting or treating plants, fruit, or animals from fungal or bacterial infections.
A use of an isolated microorganism of Bacillus amyloliquefaciens Ba-BPD1 with Accession No.:
- DSM 21836 and comprising 16S ribosomal RNA comprising a nucleotide sequence of SEQ ID NO:1, for an antimicrobial agent.
Dependencies are inferred from the claim text.